Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

75.85 +2.76 (+3.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
News headline image
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application ↗
The agency is now slated to decide on the company’s application seeking approval for the diagnostic kit by June 29. 
Via Stocktwits
News headline image
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
3 Reasons to Sell LNTH and 1 Stock to Buy Instead
What a fantastic six months it’s been for Lantheus. Shares of the company have skyrocketed 57%, hitting $83.14. This run-up might have investors contemplatin... 
Via StockStory
Topics Supply Chain
Lantheus Holdings Inc (NASDAQ:LNTH) Beats Q4 Estimates but 2026 Guidance Disappoints ↗
Via Chartmill
Lantheus Holdings Inc. (NASDAQ:LNTH) Presents a Compelling Value Investment Case ↗
Via Chartmill
Lantheus Holdings Inc (NASDAQ:LNTH) Presents a Compelling Value Case with Strong Fundamentals ↗
Via Chartmill
News headline image
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
Let’s dig into the relative performance of Lantheus (NASDAQ:LNTH) and its peers as we unravel the now-completed Q4 medical devices & supplies - imaging, diag... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Lantheus Holdings Stock Popped by Almost 12% Last Month ↗
Investors were clearly impressed by the medical device specialist's fourth-quarter performance. 
Via The Motley Fool
News headline image
Why Is LNTH Stock Up After Hours? ↗
Lantheus said that the FDA approved its PYLARIFY TruVu injection. 
Via Stocktwits
News headline image
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus (LNTH) Q4 2025 Earnings Call Transcript ↗
Lantheus (LNTH) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 4% year on year to $406.8 million. On the other hand, the company’s... 
Via StockStory
News headline image
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Earnings: What To Look For From LNTH
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings this Thursday before the bell. Here’s what to expect. 
Via StockStory
Topics Economy World Trade
News headline image
Lantheus to Present at March 2026 Investor Conferences
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
2 Value Stocks to Target This Week and 1 Facing Headwinds
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
2 Small-Cap Stocks Worth Investigating and 1 We Avoid
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
3 Market-Beating Stocks for Long-Term Investors
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
News headline image
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the... 
Via StockStory
Topics Stocks
News headline image
Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year ↗
The move suggests that shrinking margins, leadership turnover, and a shifting product mix are quietly reshaping the Lantheus investment case. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
This Healthcare Stock Still Commands a Top 3 Portfolio Slot Despite a Steep Slide This Past Year ↗
After a bruising year for the stock, one fund leaned further into a business throwing off real cash and quietly reshaping its growth engine. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Fund Adds $8.6 Million Stake in Norwegian Cruise Line Even as Shares Lag the S&P 500 by 27 Points ↗
A new position suggests some investors see more than just volatility beneath Norwegian Cruise Line’s recent underperformance. 
Via The Motley Fool
Topics Regulatory Compliance Stocks
News headline image
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus... 
Via StockStory
Topics Artificial Intelligence
News headline image
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Quantum, Unicycive, Fly-E, and Lantheus on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.